Acorah Software Products - Accounts Production 15.0.500 false true 30 November 2022 1 December 2021 false 1 December 2022 30 November 2023 30 November 2023 03079239 Mr Stefan Ogrodzinski Mr Paul Smith Professor Emeritus Mr Michael Leyland Mr Laurence Patterson Professor Emeritus Mr Stefan Ogrodzinski iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 03079239 2022-11-30 03079239 2023-11-30 03079239 2022-12-01 2023-11-30 03079239 frs-core:CurrentFinancialInstruments 2023-11-30 03079239 frs-core:Non-currentFinancialInstruments 2023-11-30 03079239 frs-core:FurnitureFittings 2023-11-30 03079239 frs-core:FurnitureFittings 2022-12-01 2023-11-30 03079239 frs-core:FurnitureFittings 2022-11-30 03079239 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2023-11-30 03079239 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2022-12-01 2023-11-30 03079239 frs-core:LandBuildings frs-core:OwnedOrFreeholdAssets 2022-11-30 03079239 frs-core:MotorVehicles 2022-12-01 2023-11-30 03079239 frs-core:PlantMachinery 2023-11-30 03079239 frs-core:PlantMachinery 2022-12-01 2023-11-30 03079239 frs-core:PlantMachinery 2022-11-30 03079239 frs-core:RevaluationReserve 2022-11-30 03079239 frs-core:RevaluationReserve 2023-11-30 03079239 frs-core:SharePremium 2023-11-30 03079239 frs-core:ShareCapital 2023-11-30 03079239 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30 03079239 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 03079239 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 03079239 frs-bus:SmallEntities 2022-12-01 2023-11-30 03079239 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 03079239 frs-bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 03079239 frs-bus:Director1 2022-12-01 2023-11-30 03079239 frs-bus:Director2 2022-12-01 2023-11-30 03079239 frs-bus:Director3 2022-12-01 2023-11-30 03079239 frs-bus:Director4 2022-12-01 2023-11-30 03079239 frs-bus:CompanySecretary1 2022-12-01 2023-11-30 03079239 frs-core:CurrentFinancialInstruments 1 2023-11-30 03079239 frs-countries:EnglandWales 2022-12-01 2023-11-30 03079239 2021-11-30 03079239 2022-11-30 03079239 2021-12-01 2022-11-30 03079239 frs-core:CurrentFinancialInstruments 2022-11-30 03079239 frs-core:Non-currentFinancialInstruments 2022-11-30 03079239 frs-core:RevaluationReserve 2022-11-30 03079239 frs-core:SharePremium 2022-11-30 03079239 frs-core:ShareCapital 2022-11-30 03079239 frs-core:RetainedEarningsAccumulatedLosses 2022-11-30 03079239 frs-core:CurrentFinancialInstruments 1 2022-11-30
Registered number: 03079239
Biostatus Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2023
Marlow Proactive
Unaudited Financial Statements
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—6
Page 1
Balance Sheet
Registered number: 03079239
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 436,007 439,106
Investments 948,151 900,484
1,384,158 1,339,590
CURRENT ASSETS
Stocks 5 3,493 4,145
Debtors 6 119,680 100,902
Cash at bank and in hand 943 2,520
124,116 107,567
Creditors: Amounts Falling Due Within One Year 7 (108,581 ) (105,089 )
NET CURRENT ASSETS (LIABILITIES) 15,535 2,478
TOTAL ASSETS LESS CURRENT LIABILITIES 1,399,693 1,342,068
Creditors: Amounts Falling Due After More Than One Year 8 (83,112 ) (110,006 )
PROVISIONS FOR LIABILITIES
Deferred Taxation (2,091 ) (2,681 )
NET ASSETS 1,314,490 1,229,381
CAPITAL AND RESERVES
Called up share capital 9 1,023 1,023
Share premium account 30,876 30,876
Revaluation reserve 10 105,057 105,057
Profit and Loss Account 1,177,534 1,092,425
SHAREHOLDERS' FUNDS 1,314,490 1,229,381
Page 1
Page 2
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Stefan Ogrodzinski
Director
09/08/2024
The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Biostatus Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 03079239 . The registered office is 56A Charnwood Road, Shepshed, Loughborough, LE12 9NP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Freehold not provided
Plant & Machinery 100% on cost, 50% on cost and 25% on cost
Motor Vehicles 33% on cost
Fixtures & Fittings 25% on cost
2.4. Leasing and Hire Purchase Contracts
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Page 3
Page 4
2.6. Taxation
Tax on Profits represents the sum of the corporation tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
2.7. Pensions
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to the profit and loss account in the period to which they relate.
2.8. Government Grant
Government grants towards research and development expenditures and in respect of patent costs are credited to the Profit and Loss account over the period in which related expenditures are incurred.
2.9. Stock
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 7 (2022: 7)
7 7
Page 4
Page 5
4. Tangible Assets
Land & Property
Freehold Plant & Machinery Fixtures & Fittings Total
£ £ £ £
Cost
As at 1 December 2022 425,000 141,574 19,165 585,739
Additions - 3,202 - 3,202
As at 30 November 2023 425,000 144,776 19,165 588,941
Depreciation
As at 1 December 2022 - 127,731 18,902 146,633
Provided during the period - 6,160 141 6,301
As at 30 November 2023 - 133,891 19,043 152,934
Net Book Value
As at 30 November 2023 425,000 10,885 122 436,007
As at 1 December 2022 425,000 13,843 263 439,106
5. Stocks
2023 2022
£ £
Stock 3,493 4,145
6. Debtors
2023 2022
£ £
Due within one year
Trade debtors 119,680 100,902
119,680 100,902
7. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Trade creditors 13,745 26,158
Bank loans and overdrafts 19,156 17,377
Corporation tax - 4,455
Other taxes and social security 10,273 7,724
VAT 1,779 358
Pension 1,159 1,440
Other creditors (Current liabilities - creditors < 1 year) 2,158 3,586
...CONTINUED
Page 5
Page 6
Accruals and deferred income 30,310 43,991
Directors' loan accounts 30,001 -
108,581 105,089
8. Creditors: Amounts Falling Due After More Than One Year
2023 2022
£ £
Bank loans 83,112 110,006
83,112 110,006
9. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 1,023 1,023
10. Reserves
Revaluation Reserve
£
As at 1 December 2022 105,057
As at 30 November 2023 105,057
11. Investment
1. Investment share capital:
Shares in group undertakings - £676 (2022 - £676)
Shares in UK associate - £510 (2022 - £510)
Shares in Poland associate - £290,255 (2022 - £281,763)
2. Investment Loans - £656,710
During the year funds were loaned from Biostatus Ltd to Biosuspensions Ltd, a company in which Biostatus Ltd owns 76% of the issued share capital. At the balance sheet date £297,359 (2022 - £274,223) was owed from Biosuspensions Ltd. This loan is not repayable until all other creditors have been repaid by Biosuspensions Ltd.
During the year funds were loaned from Biostatus Ltd to Oncotherics Ltd, a company in which Biostatus Ltd owns 39.84% of the issued share capital. At the balance sheet date £290,823 (2022 - £288,923) was owed from Oncotherics Ltd. The loan is not repayable until all other creditors have been repaid by Oncotherics Ltd.
At the balance sheet date £68,528 (2022 - £54,389) was owed from Biotherics Ltd, a company in which Biostatus Ltd owns 60% of the issued share capital. The loan is not repayable until all other creditors have been repaid by Biotherics Ltd.
Page 6